Literature DB >> 22269155

Ligand-based virtual screening and molecular docking studies to identify the critical chemical features of potent cathepsin D inhibitors.

Sugunadevi Sakkiah1, Sundarapandian Thangapandian, Keun Woo Lee.   

Abstract

Cathepsin D is a major component of lysosomes and plays a major role in catabolism and degenerative diseases. The quantitative structure-activity relationship study was used to explore the critical chemical features of cathepsin D inhibitors. Top 10 hypotheses were built based on 36 known cathepsin D inhibitors using HypoGen/Discovery Studio v2.5. The best hypothesis Hypo1 consists of three hydrophobic, one hydrogen bond acceptor lipid, and one hydrogen bond acceptor features. The selected Hypo1 model was cross-validated using Fischer's randomization method to identify the strong correlation between experimental and predicted activity value as well as the test set and decoy sets used to validate its predictability. Moreover, the best hypothesis was used as a 3D query in virtual screening of Scaffold database. Subsequently, the screened hit molecules were filtered by applying Lipinski's rule of five, absorption, distribution, metabolism, and toxicity, and molecular docking studies. Finally, 49 compounds were obtained as potent cathepsin D inhibitors based on the consensus scoring values, critical interactions with protein active site residues, and predicted activity values. Thus, we suggest that the application of Hypo1 could assist in the selection of potent cathepsin D leads from various databases. Hence, this model was used as a valuable tool to design new candidate for cathepsin D inhibitors.
© 2012 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22269155     DOI: 10.1111/j.1747-0285.2012.01339.x

Source DB:  PubMed          Journal:  Chem Biol Drug Des        ISSN: 1747-0277            Impact factor:   2.817


  6 in total

Review 1.  Bioinformatics opportunities for identification and study of medicinal plants.

Authors:  Vivekanand Sharma; Indra Neil Sarkar
Journal:  Brief Bioinform       Date:  2012-05-15       Impact factor: 11.622

2.  Cathepsin D inhibitors as potential therapeutics for breast cancer treatment: Molecular docking and bioevaluation against triple-negative and triple-positive breast cancers.

Authors:  Hasitha Shilpa Anantaraju; Madhu Babu Battu; Srikant Viswanadha; Dharmarajan Sriram; Perumal Yogeeswari
Journal:  Mol Divers       Date:  2015-11-13       Impact factor: 2.943

3.  Inhibition of Paracoccidioides lutzii Pb01 isocitrate lyase by the natural compound argentilactone and its semi-synthetic derivatives.

Authors:  Renata Silva do Prado; Ricardo Justino Alves; Cecília Maria Alves de Oliveira; Lucília Kato; Roosevelt Alves da Silva; Guilherme Oliveira Quintino; Silvio do Desterro Cunha; Célia Maria de Almeida Soares; Maristela Pereira
Journal:  PLoS One       Date:  2014-04-21       Impact factor: 3.240

4.  Computational Simulations Identified Two Candidate Inhibitors of Cdk5/p25 to Abrogate Tau-associated Neurological Disorders.

Authors:  Amir Zeb; Minky Son; Sanghwa Yoon; Ju Hyun Kim; Seok Ju Park; Keun Woo Lee
Journal:  Comput Struct Biotechnol J       Date:  2019-04-22       Impact factor: 7.271

5.  Potential natural inhibitors of xanthine oxidase and HMG-CoA reductase in cholesterol regulation: in silico analysis.

Authors:  Rishab Marahatha; Saroj Basnet; Bibek Raj Bhattarai; Prakriti Budhathoki; Babita Aryal; Bikash Adhikari; Ganesh Lamichhane; Darbin Kumar Poudel; Niranjan Parajuli
Journal:  BMC Complement Med Ther       Date:  2021-01-01

6.  Structure-Based Scaffold Repurposing toward the Discovery of Novel Cholinesterase Inhibitors.

Authors:  Satish N Dighe; Mangapathiraju Tippana; Suzannah van Akker; Trudi A Collet
Journal:  ACS Omega       Date:  2020-11-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.